Literature DB >> 16403456

Chronic CO levels have [corrected] a beneficial effect on vascular relaxation in diabetes.

Marco Di Pascoli1, Luigi Rodella, David Sacerdoti, Massimo Bolognesi, Saadet Turkseven, Nader G Abraham.   

Abstract

Heme oxygenase (HO) has been shown to provide cytoprotection to the vascular system in diabetes. Isolated femoral arteries from diabetic rats treated with cobalt protoporphyrin (CoPP) exhibited increased relaxation to acetylcholine (ACh), which was markedly decreased in control diabetic rats. In control rats treated with either CoPP or with CO releasing molecules-3 (CORM-3), but not in rats treated with biliverdin, we observed an increased dilatory response to ACh. The inhibition of guanylyl-cyclase (GC) with 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) caused a contractile response to ACh in control rats and in biliverdin-treated rats, while in rats treated with CoPP and CORM-3, the ACh dilatory effect was only decreased. Moreover, the inhibition of HO with chromium mesoporphyrin did not change the response to ACh in rats treated with CoPP, suggesting that the improving effect of overproduction of CO on vascular reactivity is due to a decrease in iNOS and the beneficial effect on vascular function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16403456     DOI: 10.1016/j.bbrc.2005.12.082

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

Review 1.  The therapeutic potential of carbon monoxide.

Authors:  Roberto Motterlini; Leo E Otterbein
Journal:  Nat Rev Drug Discov       Date:  2010-09       Impact factor: 84.694

Review 2.  Targeting heme oxygenase-1 in vascular disease.

Authors:  William Durante
Journal:  Curr Drug Targets       Date:  2010-12       Impact factor: 3.465

3.  Hypochlorous acid-induced heme oxygenase-1 gene expression promotes human endothelial cell survival.

Authors:  Yong Wei; Xiao-ming Liu; Kelly J Peyton; Hong Wang; Fruzsina K Johnson; Robert A Johnson; William Durante
Journal:  Am J Physiol Cell Physiol       Date:  2009-07-22       Impact factor: 4.249

Review 4.  Heme oxygenase: the key to renal function regulation.

Authors:  Nader G Abraham; Jian Cao; David Sacerdoti; Xiaoying Li; George Drummond
Journal:  Am J Physiol Renal Physiol       Date:  2009-07-01

5.  Heme oxygenase-1 induction does not improve vascular relaxation in angiotensin II hypertensive mice.

Authors:  David E Stec; Trinity Vera; Gerald R McLemore; Silvia Kelsen; John M Rimoldi; Rama S V Gadepalli; Michael J Ryan
Journal:  Am J Hypertens       Date:  2008-01-03       Impact factor: 2.689

6.  Antidiabetic effect of glucosaminic acid-cobalt (II) chelate in streptozotocin-induced diabetes in mice.

Authors:  Tahirou Talba; Xia Wen Shui; Qinyuan Cheng; Xin Tian
Journal:  Diabetes Metab Syndr Obes       Date:  2011-04-18       Impact factor: 3.168

7.  Induction of protective genes leads to islet survival and function.

Authors:  Hongjun Wang; Christiane Ferran; Chiara Attanasio; Fulvio Calise; Leo E Otterbein
Journal:  J Transplant       Date:  2011-12-14

Review 8.  The role of reactive oxygen species in apoptosis of the diabetic kidney.

Authors:  F A D T G Wagener; D Dekker; J H Berden; A Scharstuhl; J van der Vlag
Journal:  Apoptosis       Date:  2009-12       Impact factor: 4.677

9.  Upregulation of heme oxygenase-1 combined with increased adiponectin lowers blood pressure in diabetic spontaneously hypertensive rats through a reduction in endothelial cell dysfunction, apoptosis and oxidative stress.

Authors:  Jian Cao; George Drummond; Kazuyoshi Inoue; Komal Sodhi; Xiao Ying Li; Shinji Omura
Journal:  Int J Mol Sci       Date:  2008-12-01       Impact factor: 6.208

10.  Interaction between advanced glycation end products formation and vascular responses in femoral and coronary arteries from exercised diabetic rats.

Authors:  Maria A Delbin; Ana Paula C Davel; Gisele Kruger Couto; Gustavo G de Araújo; Luciana Venturini Rossoni; Edson Antunes; Angelina Zanesco
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.